IMC Chicago’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.99M Sell
83,800
-54,100
-39% -$4.45M ﹤0.01% 1946
2026
Q2
$9.16M Buy
137,900
+61,600
+81% +$5.21M ﹤0.01% 1603
2026
Q1
$7.58M Buy
76,300
+25,800
+51% +$3.37M ﹤0.01% 1480
2025
Q4
$6.14M Sell
50,500
-20,400
-29% -$2.56M ﹤0.01% 1584
2025
Q3
$7.95M Sell
70,900
-8,800
-11% -$1.03M ﹤0.01% 1277
2025
Q2
$10.7M Buy
79,700
+19,100
+32% +$2.1M ﹤0.01% 988
2025
Q1
$4.08M Sell
60,600
-19,800
-25% -$1.36M ﹤0.01% 1342
2024
Q4
$5.01M Buy
80,400
+61,000
+314% +$5.68M ﹤0.01% 1224
2024
Q3
$3.05M Buy
+19,400
New +$2.99M ﹤0.01% 1403

Other funds holding TMDX

IMC Chicago's TMDX Position: Q3 2026 in Review

IMC Chicago reduced its Transmedics (TMDX) stake by 72% in Q3 2026, selling an estimated $5.38M and leaving 25,124 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3109.

IMC Chicago first reported a position in TMDX in Q4 2024 and has held it in 4 quarters since. The position peaked at $6.01M in Q2 2026. 385 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • IMC Chicago held 25,124 shares of Transmedics worth $2.1M as of Q3 2026.
  • IMC Chicago sold 65,391 Transmedics shares in Q3 2026, an estimated $5.38M.
  • Transmedics made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #3109 holding.
  • IMC Chicago first reported a position in Transmedics in Q4 2024 and has held it in 4 quarters since.
  • IMC Chicago's Transmedics position peaked at $6.01M in Q2 2026.
  • 385 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.